260 related articles for article (PubMed ID: 21672483)
21. Racial Comparison of Patients Undergoing Minimally Invasive Partial Nephrectomy for Renal Masses at a Large Volume Tertiary Center.
Sands KG; Bhatt R; Vetter J; Paradis A; Chow AK; Bhayani S; Figenshau RS; Venkatesh R
J Endourol; 2021 Sep; 35(9):1365-1371. PubMed ID: 33730861
[No Abstract] [Full Text] [Related]
22. Management of renal masses in transplant allografts at an Australian kidney-pancreas transplant unit.
Su MZ; Campbell NA; Lau HM
Transplantation; 2014 Mar; 97(6):654-9. PubMed ID: 24212503
[TBL] [Abstract][Full Text] [Related]
23. Contemporary Issues Surrounding Small Renal Masses: Evaluation, Diagnostic Biopsy, Nephron Sparing, and Novel Treatment Modalities.
Leone AR; Diorio GJ; Spiess PE; Gilbert SM
Oncology (Williston Park); 2016 Jun; 30(6):507-14. PubMed ID: 27323710
[TBL] [Abstract][Full Text] [Related]
24. Minimally invasive surgery for renal cell carcinoma.
Ghoneim IA; Fergany AF
Expert Rev Anticancer Ther; 2009 Jul; 9(7):989-97. PubMed ID: 19589037
[TBL] [Abstract][Full Text] [Related]
25. Laparoscopic partial nephrectomy in the treatment of renal cell carcinoma: a minimally invasive means to nephron preservation.
Blitstein J; Ghavamian R
Expert Rev Anticancer Ther; 2008 Jun; 8(6):921-7. PubMed ID: 18533801
[TBL] [Abstract][Full Text] [Related]
26. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients.
Yu J; Zhang X; Liu H; Zhang R; Yu X; Cheng Z; Han Z; Liu F; Hao G; Mu MJ; Liang P
Radiology; 2020 Mar; 294(3):698-706. PubMed ID: 31961239
[TBL] [Abstract][Full Text] [Related]
28. Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.
Bazzi WM; Sjoberg DD; Feuerstein MA; Maschino A; Verma S; Bernstein M; O'Brien MF; Jang T; Lowrance W; Motzer RJ; Russo P
J Urol; 2015 Jun; 193(6):1911-6. PubMed ID: 25524244
[TBL] [Abstract][Full Text] [Related]
29. Surgical management of renal cell carcinoma.
Krabbe LM; Bagrodia A; Margulis V; Wood CG
Semin Intervent Radiol; 2014 Mar; 31(1):27-32. PubMed ID: 24596437
[TBL] [Abstract][Full Text] [Related]
30. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
31. Minimally invasive nephron-sparing treatments for T1 renal cell cancer in patients over 75 years: a comparison of outcomes after robot-assisted partial nephrectomy and percutaneous ablation.
Lehrer R; Cornelis F; Bernhard JC; Bigot P; Champy C; Bruyère F; Rouprêt M; Doumerc N; Bensalah CK; Olivier J; Audenet F; Tricard T; Parier B; Durand X; Durand M; Charles T; Branger N; Surlemont L; Xylinas E; Beauval JB; Barral M
Eur Radiol; 2023 Dec; 33(12):8426-8435. PubMed ID: 37466710
[TBL] [Abstract][Full Text] [Related]
32. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
33. The current management of small renal masses.
Trinh QD; Saad F; Lattouf JB
Curr Opin Support Palliat Care; 2009 Sep; 3(3):180-5. PubMed ID: 19553818
[TBL] [Abstract][Full Text] [Related]
34. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
35. Surgical and Minimally Invasive Therapies for the Management of the Small Renal Mass.
Withington J; Neves JB; Barod R
Curr Urol Rep; 2017 Aug; 18(8):61. PubMed ID: 28664237
[TBL] [Abstract][Full Text] [Related]
36. Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma.
Bekema HJ; MacLennan S; Imamura M; Lam TB; Stewart F; Scott N; MacLennan G; McClinton S; Griffiths TR; Skolarikos A; MacLennan SJ; Sylvester R; Ljungberg B; N'Dow J
Eur Urol; 2013 Nov; 64(5):799-810. PubMed ID: 23643550
[TBL] [Abstract][Full Text] [Related]
37. Trends in Percutaneous Thermal Ablation Therapies in the Treatment of T1a Renal Cell Carcinomas Rather than Partial Nephrectomy/Radical Nephrectomy.
Shakeri S; Raman SS
Semin Intervent Radiol; 2019 Aug; 36(3):183-193. PubMed ID: 31435126
[TBL] [Abstract][Full Text] [Related]
38. Renal Mass and Localized Renal Cancer: AUA Guideline.
Campbell S; Uzzo RG; Allaf ME; Bass EB; Cadeddu JA; Chang A; Clark PE; Davis BJ; Derweesh IH; Giambarresi L; Gervais DA; Hu SL; Lane BR; Leibovich BC; Pierorazio PM
J Urol; 2017 Sep; 198(3):520-529. PubMed ID: 28479239
[TBL] [Abstract][Full Text] [Related]
39. Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation.
Sanchez A; Feldman AS; Hakimi AA
J Clin Oncol; 2018 Dec; 36(36):3591-3600. PubMed ID: 30372390
[TBL] [Abstract][Full Text] [Related]
40. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I.
Campbell SC; Clark PE; Chang SS; Karam JA; Souter L; Uzzo RG
J Urol; 2021 Aug; 206(2):199-208. PubMed ID: 34115547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
